Chronic thromboembolic pulmonary hypertension
MONDO:0013024Chronic thromboembolic pulmonary hypertension (CTEPH) is characterized by the persistence of thromboemboli in the form of organized tissue obstructing the pulmonary arteries. The consequence is an increase in pulmonary vascular resistance (PVR) resulting in pulmonary hypertension (PH) and progressive right heart failure.
Also known as: CTEPH, Cteph, Dvt-negative, susceptibility to, pulmonary hypertension, chronic thromboembolic, without deep vein thrombosis, susceptibility to
59 clinical trials for this condition and its sub-types, 41 tagged with Chronic thromboembolic pulmonary hypertension itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Part of
-
Can lung patients ditch their meds after procedure? new trial investigates
Disease control Not yet recruitingThis study looks at people with a rare lung condition called CTEPH who have done well after a procedure (balloon angioplasty) and are taking a drug called riociguat. The goal is to see if stopping the drug is as safe as continuing it. About 150 participants will be randomly assig…
Phase 3 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Sep 16, 2026 00:00 UTC
-
Which drug is best for pulmonary hypertensive crisis? new trial aims to find out
Disease control Not yet recruitingThis trial will compare three drugs—dopamine, norepinephrine, and epinephrine—to see which works best for people experiencing a pulmonary hypertensive crisis, a life-threatening spike in blood pressure in the lungs. The study will enroll 75 adults with pulmonary arterial hyperten…
Sponsor: China National Center for Cardiovascular Diseases • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Could a common hormone be better for blood pressure during lung surgery?
Disease control Not yet recruitingThis study compares two drugs, vasopressin and norepinephrine, given during and after surgery to remove chronic blood clots from the lungs. The goal is to see which drug better controls blood pressure in the lungs without harming the rest of the body. About 90 adults scheduled fo…
Phase 2 • Sponsor: Fondation Hôpital Saint-Joseph • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
A tiny sensor inside the lung could reveal hidden pressure problems after Life-Saving surgery
Knowledge-focused Not yet recruitingThis study tests whether a small implanted sensor, called CardioMEMS, can continuously track blood pressure in the lung arteries after surgery for chronic thromboembolic pulmonary hypertension (CTEPH). The surgery, called pulmonary endarterectomy, can cure CTEPH, but some patient…
Sponsor: Hospital Universitario 12 de Octubre • Aim: Knowledge-focused
Last updated Aug 13, 2026 00:00 UTC
-
Toxins in hair and urine: could they trigger rare lung disease?
Knowledge-focused Not yet recruitingThis study looks at whether environmental toxins, drugs, and workplace exposures play a role in causing pulmonary arterial hypertension (PAH), a rare and serious lung condition. Researchers will compare 150 newly diagnosed patients with PAH to those with another form of pulmonary…
Sponsor: Poitiers University Hospital • Aim: Knowledge-focused
Last updated Jul 24, 2026 00:00 UTC